OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06
◂ Monitor KP2 ASX (CDIs); also AIM and JSE

Kore Potash plc

DFS Unfunded Developer · Potash · CG Rating locked: sign in to view v8.1 · kp2-20261104t223111-full
Last 2026-11-05
A$0.072
1D
—
1M
—
YTD
—
1Y
—
Upside
Locked: sign in to view
Mkt cap
A$372.7M
EV
A$364.2M
Cash
US$6.4M
Debt
US$0

Disclosed activity

Insider transactions

Reviewed 2026-10-09 20:24 UTC
Reset
Trading activity0 buys · 0 sells shownNet cash last 12 months no tradesShow chartHide chart
A$0.038A$0.062A$0.085Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26Cash/mo2025-06-11 · Jonathan Trollip · Grant · 2.0m securities2025-06-11 · David Netherway · Grant · 2.0m securities2025-06-11 · David Hathorn · Grant · 2.0m securities2025-06-11 · David Hathorn · Vesting · 9.0m securities
On-market buyPlacement / plan subscriptionSaleMarker size = cash valueGrant, exercise, expiry or transferBars: cash bought (up) and sold (down) per month

Director activity

4 reviewed events · Newest first

Reviewed Directors events in KP2
DatePerson / accountActivity / securityQuantityCash considerationPriceHolding after
2025-06-11Jonathan Trollip
Details & evidence for Jonathan Trollip on 2025-06-11

Annual report states each option was granted and vested on 11 June 2025. See option terms in Note 21.

As disclosed: Share options granted

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
—
Market
Not Disclosed
Consideration
Option grant; the annual report gives grant-date fair value but no cash consideration. Fair value is not treated as cash.
Contractual interest
Exercise price GBP 0.0193; expiry 2028-06-11
Exercise price
AUD 0.0193
Expiry
2028-06-11

director · 2017-11-17

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 131 · Note 21, Option Series 43: director-specific grant table

GrantUnlisted options Series 432,000,000—Non Cash——
2025-06-11David Netherway
Details & evidence for David Netherway on 2025-06-11

Annual report states each option was granted and vested on 11 June 2025. See option terms in Note 21.

As disclosed: Share options granted

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
—
Market
Not Disclosed
Consideration
Option grant; the annual report gives grant-date fair value but no cash consideration. Fair value is not treated as cash.
Contractual interest
Exercise price GBP 0.0193; expiry 2028-06-11
Exercise price
AUD 0.0193
Expiry
2028-06-11

director · 2017-12-12

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 131 · Note 21, Option Series 42: director-specific grant table

GrantUnlisted options Series 422,000,000—Non Cash——
2025-06-11David Hathorn
Details & evidence for David Hathorn on 2025-06-11

Annual report states each option was granted and vested on 11 June 2025. See option terms in Note 21.

As disclosed: Share options granted

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
—
Market
Not Disclosed
Consideration
Option grant; the annual report gives grant-date fair value but no cash consideration. Fair value is not treated as cash.
Contractual interest
Exercise price GBP 0.0193; expiry 2028-06-11
Exercise price
AUD 0.0193
Expiry
2028-06-11

director · 2017-08-25

Luna Nominees Limited · ordinary shares held on his behalf

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 131 · Note 21, Option Series 41: director-specific grant table

GrantUnlisted options Series 412,000,000—Non Cash——
2025-06-11David Hathorn
Details & evidence for David Hathorn on 2025-06-11

Original grant was in 2022; this event records the vesting disclosed for 11 June 2025, not a new grant.

As disclosed: Option vesting condition satisfied

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
—
Market
Not Disclosed
Consideration
Previously granted options vested after the stated vesting conditions were satisfied; no cash consideration is attributed to vesting.
Contractual interest
Exercise price GBP 0.022; expiry 2027-06-09
Exercise price
AUD 0.022
Expiry
2027-06-09

director · 2017-08-25

Luna Nominees Limited · ordinary shares held on his behalf

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 131 · Note 21, Option Series 38; vesting condition satisfied on 11 June 2025

VestingUnlisted options Series 38 (funding incentive options)9,000,000—Non Cash——
Disclosed holding observations7 dated positions

Initial, final and threshold notices describe positions; these are not counted as purchases or sales.

Holding atPerson / groupType / securityQuantityPercentage
2026-03-25David Hathorn
Details & evidence for David Hathorn on 2026-03-25

Latest annual-report option balance; date is the annual report date. The 9,000,000 Series 38 options were granted in 2022 and are a position, not a new grant in this review window.

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
9,000,000

director · 2017-08-25

Luna Nominees Limited · ordinary shares held on his behalf

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 137 · ASX additional information, unquoted equity security holdings

PositionUnlisted options Series 38 (GBP 0.022; expiry 2027-06-09)9,000,000—
2026-03-25David Hathorn
Details & evidence for David Hathorn on 2026-03-25

Latest annual-report option balance; date is the annual report date. The 9,000,000 Series 38 options were granted in 2022 and are a position, not a new grant in this review window.

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
2,000,000

director · 2017-08-25

Luna Nominees Limited · ordinary shares held on his behalf

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 137 · ASX additional information, unquoted equity security holdings

PositionUnlisted options Series 41 (GBP 0.0193; expiry 2028-06-11)2,000,000—
2026-03-25David Netherway
Details & evidence for David Netherway on 2026-03-25

Latest annual-report option balance; date is the annual report date. The 9,000,000 Series 38 options were granted in 2022 and are a position, not a new grant in this review window.

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
2,000,000

director · 2017-12-12

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 137 · ASX additional information, unquoted equity security holdings

PositionUnlisted options Series 42 (GBP 0.0193; expiry 2028-06-11)2,000,000—
2026-03-25Jonathan Trollip
Details & evidence for Jonathan Trollip on 2026-03-25

Latest annual-report option balance; date is the annual report date. The 9,000,000 Series 38 options were granted in 2022 and are a position, not a new grant in this review window.

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
2,000,000

director · 2017-11-17

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 137 · ASX additional information, unquoted equity security holdings

PositionUnlisted options Series 43 (GBP 0.0193; expiry 2028-06-11)2,000,000—
2026-02-27David Hathorn
Details & evidence for David Hathorn on 2026-02-27

David Hathorn is also a director; the company reports that the shares are held through Luna Nominees Limited. Position snapshot, not a transaction.

Interest
Indirect
Registered account
Luna Nominees Limited
Holding before
—
Holding after
395,746,326

director · 2017-08-25

Luna Nominees Limited · ordinary shares held on his behalf

Annual Report to Shareholders ↗
Published 2026-03-25 18:03 AEDT · PDF page 136 · ASX additional information, substantial shareholders/CDI holders as at 27 February 2026

PositionFully paid ordinary shares / CDIs395,746,3267.65%Issued Shares
2023-10-31Stuart Bradley Sampson
Details & evidence for Stuart Bradley Sampson on 2023-10-31

Final director-interest snapshot at the cessation date; later option status is not inferred from this notice.

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
26,900,000

director · Start not disclosed to 2023-10-31

Final Director's Interest Notice - BS ↗
Published 2023-11-06 17:52 AEDT · PDF page 1 · Appendix 3Z, Part 1(b), relevant interests at cessation

FinalUnlisted options (GBP 0.022; expiry 2024-07-19)26,900,000—
2023-10-31Stuart Bradley Sampson
Details & evidence for Stuart Bradley Sampson on 2023-10-31

Final director-interest snapshot at the cessation date; this is a position, not a transaction.

Interest
Direct
Registered account
Not separately disclosed
Holding before
—
Holding after
2,464,705

director · Start not disclosed to 2023-10-31

Final Director's Interest Notice - BS ↗
Published 2023-11-06 17:52 AEDT · PDF page 1 · Appendix 3Z, Part 1(a), relevant interests at cessation

FinalFully paid ordinary shares (AIM)2,464,705—